Your browser doesn't support javascript.
loading
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Orenes-Piñero, Esteban; Romiti, Giulio Francesco; Romanazzi, Imma; Bai, Ying; Carmo, João; Proietti, Marco; Marín, Francisco; Lip, Gregory Y H.
Afiliação
  • Esteve-Pastor MA; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain.
  • Rivera-Caravaca JM; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
  • Roldán V; Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
  • Orenes-Piñero E; Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain.
  • Romiti GF; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Romanazzi I; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Bai Y; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, China.
  • Carmo J; Cardiology Department, Santa Cruz Hospital, Western Lisbon Hospital Centre, Portugal.
  • Proietti M; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Department of Neuroscience, Milan, Italy.
  • Marín F; Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain. Electronic address: fcomarino@hotmail.com.
  • Lip GYH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Am J Cardiol ; 122(5): 785-792, 2018 09 01.
Article em En | MEDLINE | ID: mdl-30049460
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Fibrilação Atrial / Antitrombinas / Inibidores do Fator Xa / Rivaroxabana / Dabigatrana / Acenocumarol / Anticoagulantes Tipo de estudo: Etiology_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Fibrilação Atrial / Antitrombinas / Inibidores do Fator Xa / Rivaroxabana / Dabigatrana / Acenocumarol / Anticoagulantes Tipo de estudo: Etiology_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article